Literature DB >> 9746609

Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans.

K Decken1, G Köhler, K Palmer-Lehmann, A Wunderlin, F Mattner, J Magram, M K Gately, G Alber.   

Abstract

To analyze the roles of interleukin-12 (IL-12) and the IL-12-dependent Th1 response in resistance to Cryptococcus neoformans, we have established a chronic infection model in wild-type mice and in mice with targeted disruptions of the genes for the IL-12p35 and IL-12p40 subunits (IL-12p35(-/-) and IL-12p40(-/-) mice, respectively) as well as in mice with a targeted disruption of the IL-4 gene. Long-term application of exogenous IL-12 prevented death of infected wild-type mice for the entire period of the experiment (up to 180 days) but did not resolve the infection. Infected IL-12p35(-/-) and IL-12p40(-/-) mice died significantly earlier than infected wild-type mice, whereas infection of IL-4-deficient mice led to prolonged survival. Interestingly, infected IL-12p40(-/-) mice died earlier and developed higher organ burdens than IL-12p35(-/-) mice, which, for the first time in an infection model, suggests a protective role of the IL-12p40 subunit independent of the IL-12 heterodimer. The fungal organ burdens of IL-4-deficient mice and IL-12-treated wild-type mice were significantly reduced compared to those of untreated wild-type mice and IL-12-deficient mice. Histopathological analysis revealed reduction of the number of granulomatous lesions following treatment with IL-12. Susceptibility of both IL-12p35(-/-) and IL-12p40(-/-) mice was associated with marginal production of gamma interferon and elevated levels of IL-4 from CD4(+) T cells, which indicates Th2 polarization in the absence of IL-12, whereas wild-type mice developed a Th1 response. Taken together, our data emphasize the essential role of IL-12 for protective Th1 responses against C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746609      PMCID: PMC108620     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Studies on organ specificity in experimental murine cryptococcosis.

Authors:  M Miyaji; K Nishimura
Journal:  Mycopathologia       Date:  1981-12-11       Impact factor: 2.574

2.  Isolation of Cryptococcus neoformans from pigeon habitats in London.

Authors:  H S Randhawa; Y M Clayton; R W Riddell
Journal:  Nature       Date:  1965-11-20       Impact factor: 49.962

3.  Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.

Authors:  J Ohara; W E Paul
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

4.  IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6).

Authors:  G B Huffnagle; M B Boyd; N E Street; M F Lipscomb
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

5.  Monoclonal antibodies against murine gamma interferon.

Authors:  M Prat; G Gribaudo; P M Comoglio; G Cavallo; S Landolfo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Natural cellular resistance of beige mice against Cryptococcus neoformans.

Authors:  M R Hidore; J W Murphy
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

7.  Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity.

Authors:  D L Granger; J R Perfect; D T Durack
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

8.  Studies on relationship between cysts and granulomas in murine cryptococcosis.

Authors:  T Watabe; M Miyaji; K Nishimura
Journal:  Mycopathologia       Date:  1984-05-30       Impact factor: 2.574

9.  Host defense in cryptococcosis. II. Cryptococcosis in the nude mouse.

Authors:  J R Graybill; D J Drutz
Journal:  Cell Immunol       Date:  1978-10       Impact factor: 4.868

10.  Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

Authors:  A Zuger; E Louie; R S Holzman; M S Simberkoff; J J Rahal
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

View more
  107 in total

1.  Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity.

Authors:  A M Harandi; B Svennerholm; J Holmgren; K Eriksson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.

Authors:  V Michailowsky; N M Silva; C D Rocha; L Q Vieira; J Lannes-Vieira; R T Gazzinelli
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Authors:  Amy C Herring; John Lee; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 4.  Role of CD1d-restricted NKT cells in microbial immunity.

Authors:  Markus Sköld; Samuel M Behar
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

5.  Endogenous interleukin-12 is not required for resolution of Chlamydophila abortus (Chlamydia psittaci serotype 1) infection in mice.

Authors:  L Del Río; A J Buendía; J Sánchez; M C Gallego; M R Caro; N Ortega; J Seva; F J Pallarés; F Cuello; J Salinas
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.

Authors:  L Pitzurra; R Cherniak; M Giammarioli; S Perito; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

7.  Intraoperative subcutaneous or intrasplenic vaccination with modified autologous tumor cells leads to enhanced survival in a mouse tumor model.

Authors:  Arne Dietrich; Christoph Stockmar; Gabriela Aust; Susan Endesfelder; Anke Guetz; Ulrich Sack; Manfred Schoenfelder; Johann Hauss
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-04       Impact factor: 4.553

8.  Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production.

Authors:  Benjamin J Murdock; Gary B Huffnagle; Michal A Olszewski; John J Osterholzer
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

Review 9.  The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases.

Authors:  Christoph Hölscher
Journal:  Med Microbiol Immunol       Date:  2003-06-27       Impact factor: 3.402

10.  IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis.

Authors:  Werner Stenzel; Uwe Müller; Gabriele Köhler; Frank L Heppner; Manfred Blessing; Andrew N J McKenzie; Frank Brombacher; Gottfried Alber
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.